Jun 15, 2020
InfoBionic Plays Crucial Role in Monitoring Pandemic Lockdown Heart Effects
May 26, 2020
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction
May 13, 2020
Join ACC, Global Partners for Dedicated Week of Action on NCDs
Mar 12, 2020
Association of Black Cardiologists Endorses Black Maternal Health Momnibus
Mar 12, 2020
Cardiovascular Drug Delivery Market Insights, 2018-2028 Featuring Profiles of 82 Companies and 80 Collaborations
Mar 03, 2020
Cardiac Biomarker Diagnostic Kits Market by Product Type, Disease Indication, Testing and Geography - Forecast to 2027
Mar 03, 2020
Global Cardiovascular Disease Monitoring and Diagnostic Devices Industry
Feb 28, 2020
Are We Doing Enough To Protect Our Hearts?: Millions Of Patients Face Continued Cardiovascular Risk
Feb 27, 2020
NACDS Announced as Founding Member of CDC Hypertension Effort
Feb 21, 2020
Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease
Feb 18, 2020
The Europe immunochemistry market is expected to reach US$ 775.97 Mn in 2027 from US$ 430.82 Mn in 2018
Feb 03, 2020
How to Reduce Your Risk for Another Heart Attack
Jan 13, 2020
IDTechEx Report Discusses Diagnosing Cardiovascular Disease
Jan 02, 2020
Global Call To Action on Familial Hypercholesterolemia Aims to Improve Diagnosis and Treatment Worldwide
Nov 27, 2019
IDTechEx Research Reports: The Cardiovascular Disease Technology Market Will Exceed $40 Billion by 2030
Nov 26, 2019
American Heart Association: Avoiding the Deadly Holiday Heart Attack
Nov 21, 2019
Global Cardiovascular Deal Trends, Players and Financials Partnering Directory 2019
Nov 16, 2019
Pharmascience Inc. contributes to the Montreal Heart Institute's COLchicine Cardiovascular Outcome Trial (COLCOT), a landmark study to benefit cardiovascular patients and the healthcare system
Nov 14, 2019
HDL Cholesterol Function Lab Test Offers Novel Insight into Cardiovascular Disease Risk, Reports Quest Diagnostics at American Heart Association 2019 Scientific Sessions
Nov 14, 2019
Corvidia Therapeutics to Present New Data at the American Heart Association's Scientific Sessions 2019